Chronic kidney disease trials in China

In China 120 Also abroad 798

120 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 4Taking people
QUARTET-DKD: Quadruple Therapy for Type 2 Diabetic Nephropathy
Where
Shanghai
Age
18 years to 70 years
People
820
Run by
Huijie Zhang
See details and how to joinNCT07775846
Phase 3Taking people
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Where
Baotou, Beijing, Changchun, Changsha, Changzhou, Chengdu, Chongqing, Dongwan, Fuyang, Guangzhou, Haikou, Hefei, Hengyang, Heze, Huaian, Jiaxing, Jilin City, Jinan, Jinhua, Jining, Lanzhou, Linhai, Linyi, Luoyang, Nanchang, Nanning, Ningbo, Panjin, Pingxiang, Shanghai, Shantou, Shenyang, Shenzhen, Suzhou, Taian, Tianjin, Wanzhou, Wuhan, Wuxi, Xi'an, Xianyang, Yantai, Yinchuan, Zhengzhou, Zhongshan, Zhuzhou, Zigong
Age
18 years and over
People
5,000 worldwide
Run by
AstraZeneca
See details and how to joinNCT06742723 · EU 2023-506460-14-00
Phase 3Taking people
Study of MT1013 for the Treatment of Patients With Secondary Hyperparathyroidism
Where
Shanghai
Age
18 years and over
People
424
Run by
Shaanxi Micot Pharmaceutical Technology Co., Ltd.
See details and how to joinNCT07122401
Phase 3Taking people
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
Where
Beijing, Changchun, Changde, Changzhou, Chengdu, Chongqing, Dalian, Guangzhou, Hangzhou, Harbin, Jinan, Jingjiang, Jingzhou, Lishui, Luoyang, Luoyang Shi, Nanchang, Nanjing, Shanghai, Shantou, Suzhou, Wuhan, Xi'an, Xuzhou, Zigong
Age
50 years and over
People
7,140 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07241390 · EU 2025-523123-22-00
Phase 2Taking people
UBT251 Injection Phase II Clinical Study (CKD)
Where
Beijing
Age
18 years to 75 years
People
180
Run by
The United Bio-Technology (Hengqin) Co., Ltd.
See details and how to joinNCT07134335
Phase 2Taking people
Evaluate the Efficacy and Safety of ABP-671 in Subjects With Chronic Kidney Disease and Hyperuricaemia
Where
Beijing, Hangzhou, Nanjing, Shanghai
Age
18 years to 75 years
People
80 worldwide
Run by
Atom Therapeutics Co., Ltd
See details and how to joinNCT07323095
Phase 4Taking people
A Research Study Looking at Kidney and Heart Health in Adults With Type 2 Diabetes and Chronic Kidney Disease Treated With Semaglutide in China
Where
Anyang, Baotou, Beijing, Changchun, Changzhou, Chengdu, Dalian, Fuyang, Huizhou, Jinan, Lanzhou, Linhai, Nanjing, Ningbo, Panjin, Pingxiang, Shanghai, Shantou, Shijiazhuang, Siping, Xining, Yibin, Yichang, Zhenjiang
Age
18 years and over
People
300
Run by
Novo Nordisk A/S
See details and how to joinNCT07900438
Phase 2Taking people
Safety and Tolerability of Difelikefalin in Adolescents on Haemodialysis With Moderate-to-Severe Pruritus
Where
Chengdu, Guangzhou, Hangzhou, Shanghai, Wuhan, Xi'an
Age
12 years to 18 years
People
18 worldwide
Run by
Vifor Fresenius Medical Care Renal Pharma
See details and how to joinNCT06593392 · EU 2023-509909-74-00
No phaseEnrolling by invitation
Strategies for Proactive Health in People With Kidney Function Decline
Where
Shanghai
Age
18 years to 90 years
People
1,800
Run by
Huashan Hospital
See details and how to joinNCT07245186
No phaseNot yet taking people in China
Impact of AI-Based Breath Ammonia Kidney Function Results on Clinical Pharmacist Medication Recommendations
Where
Shanghai
Age
18 years and over
People
380
Run by
Shanghai Pudong Hospital
See details and how to joinNCT07888855
Phase 4Not yet taking people in China
Study on the Safety and Efficacy of a Time-of-Day-Based Individualized Tacrolimus Dosing Regimen in Kidney Transplant Recipients
Where
Guangzhou
Age
18 years to 70 years
People
100
Run by
The First Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT07877103
No phaseTaking people
HAPA-based Intervention in Adults With Metabolic Syndrome and Chronic Kidney Disease
Where
Chengdu
Age
18 years and over
People
160
Run by
Chinese University of Hong Kong
See details and how to joinNCT06715735
Phase 3Taking people
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
Where
Beijing, Changchun, Changsha, Guangzhou, Luoyang, Ningbo, Qingdao, Shanghai, Shenzhen, Taiyuan, Ürümqi, Wenzhou, Xian, Yinchuan, Zhengzhou
Age
18 years to 100 years
People
540 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT04557462 · EU 2023-508690-92-00
Phase 2Not yet taking people in China
A Phase 2 Study to Evaluate the Efficacy and Safety of DR10624 in Subjects With Moderate Hypertriglyceridemia and Diabetic Kidney Disease
Where
Beijing
Age
18 years to 75 years
People
315
Run by
Zhejiang Doer Biologics Co., Ltd.
See details and how to joinNCT07848880
Phase 3Taking people
A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)
Where
Baotou, Beijing, Changchun, Changsha, Changzhou, Chengdu, Chongqing, Dongguan, Dongyang, Ganzhou, Guangzhou, Guiyang, Hebei, Hohhot, Huaian, Jinan, Jining, Jiujiang, Linhai, Nanchang, Nanjing, Nanning, Ningbo, Panjin, Pingxiang, Qingzhou, Shanghai, Shantou, Shenyang, Shenzhen, Suzhou, Ürümqi, Wuhan, Wuxi, Xiamen, Xuzhou, Yancheng, Yangzhou, Yantai, Yibin, Yinchuan, Zhenjiang, Zhuzhou
Age
18 years to 99 years
People
2,800 worldwide
Run by
AstraZeneca
See details and how to joinNCT07624305 · EU 2026-526114-90-00
No phaseEnrolling by invitation
Clinical Study on a New Diagnostic Strategy for Osteoporosis and Sarcopenia in Chronic Kidney Disease Patients Based on MRI-FF
Where
Beijing
Age
18 years to 80 years
People
868
Run by
Capital Medical University
See details and how to joinNCT07645794
Phase 2/3Taking people
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
Where
Baotou Shi, Beijeing, Beijing, Chengdu, Dalian, Deyang Shi, Dongguan, Foshan Shi, Guangzhou, Hefei, Jiaxing, Lanzhou, Luoyang Shi, Mianyang, Nanchang, Nanjing, Nanning, Pingxiang, Shanghai, Shanghai Shi, Shenzhen, Shijiazhuang, Taiyuan, Tianjin, Wuhan, Wuxi, Xiamen, Xianyang, Xinxiang, Yangzhou, Yibin, Zhengzhou, Zhenjiang
Age
18 years and over
People
3,110 worldwide
Run by
CSL Behring
See details and how to joinNCT05485961 · EU 2022-500273-14-00
Phase 1Taking people
Human Umbilical Cord Mesenchymal Stem Cell Injection for Diabetic Nephropathy
Where
Wuhan
Age
30 years to 70 years
People
15
Run by
Tongji Hospital
See details and how to joinNCT07822152
No phaseTaking people
Efficacy and Safety of Nalfurafine Hydrochloride ODT for Moderate-to-Severe Pruritus in Patients on Peritoneal Dialysis
Where
Guangzhou
Age
18 years to 85 years
People
93
Run by
Guangdong Provincial People's Hospital
See details and how to joinNCT07098351
Phase 3Taking people
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
Where
Baoding, Beijing, Changchun, Changsha, Changzhou, Chengdu, Chenzhou, Chongqing, Dongguan, Foshan, Ganzhou, Guangzhou, Guiyang, Hefei, Huangshi, Huizhou, Jiangmen, Jining, Linfen, Luoyang, Nanchang, Nanjing, Nanning, Ningbo, Panjin, Pingxiang, Qingzhou, Sacramento, Shanghai, Shantou, Shenzhen, Shijiazhuang, Tianjin, Ürümqi, Wuhan, Wuxi, Xi'an, Xuzhou, Yancheng, Yangzhou, Yantai, Yibin, Zhenjiang, Zhongshan, Zigong, Zunyi
Age
18 years and over
People
7,000 worldwide
Run by
AstraZeneca
See details and how to joinNCT07753993 · EU 2025-523994-41-00
Phase 4Taking people
Use of Pegmolesatide in Renal Anemia: Efficacy and Safety of Switching to Pegmolesatide in Non-dialysis CKD Patients Treated With rhuEPO or HIF-PHI
Where
Dalian
Age
18 years to 80 years
People
160
Run by
The First Affiliated Hospital of Dalian Medical University
See details and how to joinNCT06946394
Phase 3Taking people
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
Where
Binzhou, Changsha, Chengdu, Hangzhou, Jinan, Liaocheng, Liuzhou, Luoyang, Nanjing, Nanyang, Suining Shi, Yibin, Yichang, Zhengzhou
Age
18 years and over
People
900 worldwide
Run by
AstraZeneca
See details and how to joinNCT07662135 · EU 2025-523940-12-00
Phase 2Taking people
A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
Where
Beijing, Chengdu, Nanjing, Shanghai, Zhengzhou
Age
18 years and over
People
168 worldwide
Run by
R1 Therapeutics
See details and how to joinNCT06712654
No phaseTaking people
Clinical Effectiveness and Resource Use in End-Stage Renal Disease Patients: Remote Patient Monitoring Across Dialysis Modalities
Where
Baotou, Beijing, Changchun, Changsha, Chongqing, Guangzhou, Hangzhou, Harbin, Qingdao, Shanghai, Shijiazhuang, Tianjin, Wuhan, Wuxi, Xi’an, Yantai, Zhengzhou
Age
18 years to 79 years
People
750
Run by
Vantive Health LLC
See details and how to joinNCT07781124
No phaseTaking people
LineMatrix® Biological Vascular Graft for the Creation of Arteriovenous Graft
Where
Beijing, Chongqing, Hangzhou, Nanchang, Nanjing, Shanghai, Shenzhen, Shijiazhuang, Wuhan, Xi’an, Zhengzhou
Age
18 years to 80 years
People
326
Run by
Longhua Hospital
See details and how to joinNCT07773051